MedPath

Indium 111 Oxyquinolone

Indium 111 Oxyquinolone (In-111 Oxine)

Approved
Approval ID

eadcaf93-c53e-41b6-aebb-7e7d57f5b303

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 19, 2012

Manufacturers
FDA

AnazaoHealth Corporation

DUNS: 011038762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Indium 111 Oxyquinolone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51808-126
Product Classification
G
Generic Name
Indium 111 Oxyquinolone
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 8, 2012
FDA Product Classification

INGREDIENTS (3)

POLYSORBATE 80Inactive
Quantity: 100 ug in 1 mL
Code: 6OZP39ZG8H
Classification: IACT
INDIUM IN-111 OXYQUINOLINEActive
Quantity: 2 mCi in 1 mL
Code: LGX9OL562T
Classification: ACTIB
HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACIDInactive
Quantity: 6 mg in 1 mL
Code: RWW266YE9I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Indium 111 Oxyquinolone - FDA Drug Approval Details